22-30555657-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001318104.2(GAL3ST1):c.568G>A(p.Gly190Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00017 in 1,613,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001318104.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GAL3ST1 | NM_001318104.2 | c.568G>A | p.Gly190Ser | missense_variant | 4/4 | ENST00000406361.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GAL3ST1 | ENST00000406361.6 | c.568G>A | p.Gly190Ser | missense_variant | 4/4 | 2 | NM_001318104.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000324 AC: 81AN: 250336Hom.: 0 AF XY: 0.000317 AC XY: 43AN XY: 135596
GnomAD4 exome AF: 0.000168 AC: 246AN: 1461388Hom.: 0 Cov.: 33 AF XY: 0.000169 AC XY: 123AN XY: 727006
GnomAD4 genome AF: 0.000191 AC: 29AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2021 | The c.568G>A (p.G190S) alteration is located in exon 4 (coding exon 2) of the GAL3ST1 gene. This alteration results from a G to A substitution at nucleotide position 568, causing the glycine (G) at amino acid position 190 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at